A rare hereditary mechanobullous disorder called epidermolysis bullosa (EB) causes blistering in the skin and the mucosal membranes. To date, nineteen EB-related genes have been discovered in human and other species. We describe here a novel EB variant in dogs. Two newborn littermates of Central Asian Shepherd dogs with severe signs of skin blistering were brought to a veterinary clinic and euthanized due to poor prognosis. In post-mortem examination, the puppies were shown to have findings in the skin and the mucosal membranes characteristic of EB. A whole-genome sequencing of one of the affected puppies was performed to identify the genetic cause. The resequencing data were filtered under a recessive model against variants from 31 other dog genomes, revealing a homozygous case-specific nonsense variant in one of the known EB-causing genes, COL7A1 (c.4579C>T, p.R1527*). The variant results in a premature stop codon and likely absence of the functional protein in the basement membrane of the skin in the affected dogs. This was confirmed by immunohistochemistry using a COL7A1 antibody. Additional screening of the variant indicated full penetrance and breed specificity at ~28% carrier frequency. In summary, this study reveals a novel COL7A1 variant causing recessive dystrophic EB and provides a genetic test for the eradication of the disease from the breed.
Citation: Niskanen J, Dillard K, Arumilli M, Salmela E, Anttila M, Lohi H, et al. (2017) Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in Central Asian Shepherd dogs. PLoS ONE12(5): e0177527. https://doi.org/10.1371/journal.pone.0177527
Editor: Florence Ruggiero, Ecole normale superieure de Lyon, FRANCE
Received: December 13, 2016; Accepted: April 29, 2017; Published: May 11, 2017
Copyright: © 2017 Niskanen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The genome data is freely available under accession no. PRJNA380744 (http://www.ebi.ac.uk/ena/data/view/PRJNA380744) at the European Nucleotide Archive.
Funding: This work was supported by the Academy of Finland, grant number 1268091 (http://www.aka.fi/) (HL); the Jane and Aatos Erkko Foundation (http://jaes.fi/) (HL); Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/) (HL); the Orion Research Foundation (http://www.orion.fi/en/rd) (HL); the Morris Animal Foundation-D13CA-403 (http://www.morrisanimalfoundation.org/) (MKH); and the Jenny and Antti Wihuri Foundation (http://wihurinrahasto.fi/) (ES).
Competing interests: We have read the journal's policy and the authors of this manuscript have the following competing interests: Genetic test is available from Genoscoper Ltd, which is partly owned by HL. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Epidermolysis bullosa (EB) belongs to a group of rare inherited skin conditions characterized by development of blisters in the dermo-epidermal junction. EB is divided into several subtypes based on structural changes in the skin, the mode of inheritance, and clinical, microscopic and immunohistochemical findings (1). The four main types include EB simplex (EBS), junctional EB (JEB), dystrophic EB (DEB) and Kindler syndrome (KS), which differ in their phenotype and genotype; a common feature of all of them is the fragility of the skin and mucosae due to defects in the structural proteins of the basement membrane zone . The level of cleavage between the dermis and the epidermis varies by the subtype, and is located in the basal or suprabasal cell layer in EBS, in the lamina lucida in JEB or below the lamina densa in DEB . Multiple levels of cleavage within basal keratinocytes, lamina lucida or sublamina densa region are found in the KS . EB is clinically highly heterogeneous with subtype-specific symptoms but distinguishing features include blisters and skin erosions, milia, nail defects, granulation tissue, keratoderma and dyspigmentation . The disease onset varies between birth and early infancy .
A wide range of genetic causes for EB have been identified, reflecting the heterogeneous clinical picture. The list of nineteen known recessive or dominant EB genes include COL7A1, COL17A1, DSP, DST, EXPH5, FERMT1, ITGA3, ITGA6, ITGB4, JUP, KLHL24, KRT5, KRT14, LAMA3, LAMB3, LAMC2, PLEC, PKP1 and TGM5 [3,4]. To date, defects in four of them have been linked to different types of canine EB: a premature stop codon in PKP1 causing ectodermal dysplasia-skin fragility syndrome , a nonsense mutation in PLEC causing EBS , an insertion in LAMA3 causing JEB  and a missense mutation in COL7A1 causing a mild form of DEB . Additional EB cases with unknown molecular background have been described in German Shorthaired Pointers and mixed-breed dogs with JEB as well as in Akita Inu with DEB . We describe here a novel recessive and severe form of dystrophic EB in Central Asian Shepherd (CAS) dogs with a nonsense variant in COL7A1.
Histological analysis reveals typical features of EB
Two CAS dogs from a litter of eight puppies were brought to a veterinary clinic soon after birth due to severe skin lesions, blisters and ulcers on feet, ears, muzzle and oral mucosa. Epidermolysis bullosa was suspected and the affected dogs were euthanized due to a poor prognosis and sent for necropsy.
Both puppies had multiple vesicles, bullae and ulcers in the oral and oropharyngeal mucosa, inner pinnae, dorsal plane of the nose, ventral abdomen, external genitalia, metacarpal and metatarsal skin and footpads (Fig 1). Histologically, there was separation at the dermal-epidermal junction with cleft formation. Small and large vacuoles were detected at the basement membrane (Fig 2A and 2B). Some of the large vacuoles were confluent, resulting in a split at the basement membrane. PAS-positive material, suggestive of basement membrane, was found on the roof and/or floor in the bullae and strands crossing the bullae were seen in the larger clefts (Fig 2C). The larger clefts included numerous mononuclear cells, neutrophils, necrotic debris and erythrocytes denoting secondary inflammation. No specific macroscopic or histological changes were present in the brain, the respiratory and gastrointestinal tract, heart, liver, spleen, pancreas, kidneys, thyroid and adrenal glands and gonads.
(A) Large erupted blisters were present on the nasal plane, lips and dorsal skin of the front paws. (B) Large intact and erupted blisters were also present in the inner ear lobe. (C) Numerous intact bullae were found on the digital pads and the erupted blisters of metacarpal and carpal pads resulted in the formation of large ulcers.
(A) Small vacuoles at the basement membrane (arrowheads) (63X). (B) Larger, confluent vacuoles result in a split along the basement membrane zone (arrowheads) (63X). (C) Large subepidermal cleft with PAS-positive material, suggestive of basement membrane, on the roof and floor of the cleft and strands crossing the bulla (arrows) (20X). Epidermis is denoted with “E” and dermis with “D”.
COL7A1 truncation confirms dystrophic EB
EB is inherited either in a recessive or dominant manner. A recessive mode of inheritance was suspected in the CAS pedigree as the two severely affected CAS dogs were born to healthy parents (Fig 3). The whole genome of one affected puppy was sequenced with an average coverage of 13X. Altogether 6 880 938 variants were called, of which 2 776 951 were homozygous. The variants were filtered against whole-genome data from 31 other dogs (Table 1) under recessive model. This decreased the number of homozygous coding variants to 401 and only one of them was found in the known EB genes, a nonsense variant at chr20:40,532,043 in the COL7A1 gene (c.4579C>T, p.R1527*) (Fig 4). This variant results in a premature stop codon in the 45th exon (p.R1527*) and a predicted early truncation of COL7A1 (Fig 4).
The COL7A1 variant genotype is denoted for individuals that were tested. White symbol denotes wild type (C/C), half-filled heterozygous carrier (C/T) and black symbol homozygous mutant (T/T), while grey denotes that no sample was available for testing. The whole genome was sequenced from the affected dog surrounded with a square.
(A) Three genotypes are present in the Central Asian Shepherd Dog cohort: wild type C/C, heterozygous carrier C/T and homozygous mutant T/T. The mutation causes a change from arginine (CGA) to a stop codon (TGA). (B) The domain structure of collagen VII. The substitution site p.R1527* is located near the beginning of the characteristic triple-helical domain. (C) A schematic presentation of the dimerization of collagen VII homotrimers. If the abnormal COL7A1 is translated the p.R1527* substitution results in severe truncation of the protein, preventing the dimerization of collagen VII at the C-terminal end.
The identified COL7A1 variant was selected as a prime candidate for EB in the CAS dogs for three reasons. First, COL7A1 defects are known to cause recessive dystrophic EB in human and animals [9,10]. Second, the identified homozygous nonsense variant is predicted to result in the severe truncation of the COL7A1 protein, which very likely renders it non-functional. Finally, none of the other genes with coding variants are known to cause EB in any species and appeared therefore unlikely to be causal. To understand the penetrance, prevalence and specificity of the mutation, we genotyped the identified COL7A1 variant in the second affected dog, the unaffected littermates, the parents, and additional 37 non-EB CAS dogs available in our biobank. The second affected dog was also homozygous for the nonsense variant while the parents and the unaffected littermates were carriers, indicating a complete segregation of the mutation with the disease. The mutation was absent in 143 dogs from related breeds (Table 2), and found only in the CAS breed at 27.7% carrier frequency.
To study the effect of the truncation mutation on the expression of COL7A1, we performed immunohistochemical staining in the skin samples of the affected puppies and age-matched controls using a COL7A1 antibody. In the control skin, a strong linear positive collagen VII staining was detected in the basement membrane zone of the epidermis (Fig 5A). In the affected puppies, the basement membrane zone was completely negative for collagen VII (Fig 5B). These results demonstrate the absence of functional COL7A1 in the affected dogs.
(A) The basement membrane zone between the epidermis and dermis is positive for collagen VII in the haired skin of the flank of an unaffected control. (100X) (B) The basement membrane zone between the intact epidermis and dermis and the roof and floor of the vacuoles during early cleft formation are negative for collagen VII in the haired skin of the inner ear lobe of an affected puppy (100X). Epidermis is denoted with “E” and dermis with “D”.
We discovered a novel pathological COL7A1 variant that results in a premature stop codon and subsequently causes recessive dystrophic epidermolysis bullosa (RDEB) in the CAS breed. RDEB is a subtype of EB that is characterized by generalized blistering and scarring of the skin as well as extracutaneous complications, such as failure to thrive, multifactorial anemia, pseudosyndactyly and esophageal strictures [1,11]. The clinical symptoms of the two affected CAS dogs were very similar to those of human RDEB, especially in terms of the severity, the onset at birth, failure to thrive, and the extent of the skin lesions. The macroscopic and histological changes in the skin were also typical of EB. In human dystrophic EB patients, over 300 COL7A1 mutations have been found, and they include nonsense, missense, deletion, insertion, insertion-deletion, splice-site and regulatory mutations . Generally, the type and position of the mutation correlates with the severity of the phenotype, and premature stop codons in the triple-helical domain often have serious effects .
In the case of the CAS dogs, the premature stop codon in COL7A1 results in the absence of functional COL7A1. It is possible that the abnormal transcript either undergoes nonsense-mediated decay or, if stable enough to be translated, produces a severely truncated COL7A1 protein, which in turn is unstable, or fails to be deposited at the dermal-epidermal junction. The lack of COL7A1 expression was confirmed by IHC staining in the skin of the affected dogs. During maturation, three COL7A1 subunits are assembled into collagen VII homotrimers, the NC2 domain in the C-terminus is proteolytically processed, and two homotrimers are linked from their C-terminal ends with disulfide bonds to form dimers . The possible truncated COL7A1 would lack C-terminal ends, which are required to link the dimers, and therefore the assembly of the anchoring fibrils would be compromised in the affected dogs.
The CAS disease represents a severe form of RDEB, consistent with the nonsense COL7A1 variant. Another canine RDEB model has been previously described in Golden Retrievers with a missense mutation in COL7A1 (c.5761G>A, p.G1906S) [8,13]. The affected dogs were reported to suffer from a mild form of the disorder, however, a more detailed description was not provided for comparison with the CAS dogs.
No cure for EB exists. Multiple treatments have been studied, including gene, recombinant protein and cell therapies, gene editing and induced pluripotent stem cells (iPSC) [14–21]. Regarding RDEB specifically, the goal of gene therapy would be to restore the collagen VII function in epithelial tissues. The Golden Retriever RDEB model has been utilized to study cell therapy, such as the clinical effects of ex vivo corrected keratinocyte grafts [8,22]. The severity of EB in the CAS dogs challenges their utilization in intervention studies, and therefore, the major impact of our gene discovery is that it enables an efficient identification of the carrier dogs and subsequent eradication of this serious disease through revised breeding programs.
Materials and methods
Sample collection in Finland was ethically approved by the Animal Ethics Committee of State Provincial Office of Southern Finland (ESAVI/7482/04.10.07/2015). All samples were collected from privately owned dogs by owner’s consent.
A CAS litter of eight puppies was born at term. Two puppies (male and female) were euthanized at owner’s request soon after birth due to severe lesions in the haired skin and oral mucosa, and the affected puppies were taken to necropsy. The puppies were euthanized by a veterinarian, and the euthanization consisted of intramuscular sedation followed by administration of a lethal overdose of intravenous anesthetic. During necropsy, a liver sample was collected and frozen for later DNA isolation. EDTA blood was collected from the healthy littermates, parents and other unaffected dogs from the breed. The samples were stored at -20°C. Genomic DNA was extracted using the semi-automated Chemagen extraction robot (PerkinElmer ChemagenTechnologie GmbH). DNA concentration was determined either with NanoDrop ND-1000 UV/Vis Spectrophotometer or Qubit 3.0 Fluorometer (Thermo Fisher Scientific Inc). Pedigree data were obtained from the public databases of the Finnish Kennel Club (http://jalostus.kennelliitto.fi/) and the Estonian Kennel Club (http://register.kennelliit.ee/). The pedigree was constructed with the AncesTrim software  and rendered with GenoPro (http://www.genopro.com/).
A full necropsy was performed on both puppies. Tissue samples of the skin, oral mucosa, internal organs and brain were collected for histological examination. The tissue samples were formalin fixed, routinely processed, paraffin embedded, sectioned at 4 μm thickness and stained with hematoxylin and eosin (HE). Skin samples were also stained with the periodic acid–Schiff (PAS) stain to delineate the zone of separation at the dermo-epidermal junction. Healthy control skin samples for IHC staining were collected at necropsy from two puppies of different breeds that had died due to other diseases.
We performed whole-genome sequencing on one affected Central Asian Shepherd dog. A fragment library with a median insert size of 400 bp was prepared and sequenced on Illumina HiSeq2500 to generate paired-end reads of 2*125 bp. Mapping, variant calling and subsequent data analysis was performed as previously described in Hytönen et al. 2016 .
Genomic DNA analysis
Cohorts of 47 Central Asian Shepherd dogs and several related breeds, including 39 Caucasian Shepherd Dogs, 76 Tibetan Mastiffs, 3 South Russian Ovcharkas, 6 Kuvasz and 19 Slovakian Chuvach, were genotyped for the COL7A1 c.4579C>T variant. Genotyping of the variant was performed by standard PCR with the following primers: 5’-CTCTGCTCTTCTTCCCCAGG-3’ and 5’-CCTCCCTCTGCTTACCACTG-3’. The amplified PCR products were sequenced with a capillary sequencer and the sequence data were analyzed using Sequencher 5.1 (GeneCodes).
The skin samples of two affected puppies were sectioned at 4 μm thickness and deparaffinized. Antigen retrieval was done with Proteinase K for 5 minutes at 37°C. The primary collagen VII antibody (Monoclonal Anti-Collagen, Type VII Antibody, clone LH7.2, SAB4200686, Sigma-Aldrich, USA) was incubated for two hours at 37°C with a dilution of 1:50. The tissue sections were stained with UltraVision LP Detection System HRP polymer and AEC chromogen kit (Thermo Fischer Scientific Inc., USA). The staining was performed according to the protocol of the kit without the hydrogen peroxide block step. Skin samples collected at necropsy from two 0 to 2-day-old puppies with normal skin were used as controls.
DVM Lauri Kareinen is thanked for the introduction of the affected cases, and Sini Karjalainen, Ranja Eklund, Katri Vainio-Siukola and Jere Linden for excellent technical assistance. We thank all dog breeders and owners who contributed samples and participated in this study.
- Conceptualization: MKH HL.
- Data curation: ES M. Arumilli.
- Funding acquisition: HL MKH ES.
- Investigation: JN MKH KD.
- Project administration: HL MKH.
- Resources: HL M. Anttila.
- Supervision: MKH HL M. Anttila.
- Validation: JN KD MKH HL.
- Visualization: JN KD.
- Writing – original draft: JN MKH HL M. Anttila.
- Writing – review & editing: JN KD M. Arumilli ES M. Anttila HL MKH.
- 1. Fine JD. Inherited epidermolysis bullosa. Orphanet J Rare Dis. 2010;5: 12. pmid:20507631
- 2. Fine JD, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70: 1103–1126. pmid:24690439
- 3. Lin Z, Li S, Feng C, Yang S, Wang H, Ma D, et al. Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility. Nat Genet. 2016;48: 1508–1516. pmid:27798626
- 4. Uitto J, Has C, Vahidnezhad H, Youssefian L, Bruckner-Tuderman L. Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa. Matrix Biol. 2017;57–58: 76–85. pmid:27496350
- 5. Olivry T, Linder KE, Wang P, Bizikova P, Bernstein JA, Dunston SM, et al. Deficient Plakophilin-1 Expression Due to a Mutation in PKP1 Causes Ectodermal Dysplasia-Skin Fragility Syndrome in Chesapeake Bay Retriever Dogs. PLoS ONE. 2012;7: 1–9.
- 6. Mauldin EA, Wang P, Olivry T, Henthorn PS, Casal ML. Epidermolysis bullosa simplex in sibling Eurasier dogs is caused by a PLEC non-sense variant. Vet Dermatol. 2017;28: 10–e3. pmid:27878870
- 7. Capt A, Spirito F, Guaguere E, Spadafora A, Ortonne JP, Meneguzzi G. Inherited Junctional Epidermolysis Bullosa in the German Pointer: Establishment of a Large Animal Model. J Invest Dermatol. 2005;124: 530–535. pmid:15737193
- 8. Baldeschi C, Gache Y, Rattenholl A, Bouillé P, Danos O, Ortonne JP, et al. Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet. 2003;12: 1897–1905. pmid:12874109
- 9. Medeiros GX, Riet-Correa F. Epidermolysis bullosa in animals: a review. Vet Dermatol. 2015;26: 3. pmid:25354580
- 10. Dang N, Murrell DF. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol. 2008;17: 553–568. pmid:18558993
- 11. Fine JD, Johnson LB, Weiner M, Suchindran C. Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry. J Pediatr Gastroenterol Nutr. 2008;46: 147–158. pmid:18223373
- 12. Keene DR, Sakai LY, Lunstrum GP, Morris NP, Burgeson RE. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol. 1987;104: 611–621. pmid:3818794
- 13. Palazzi X, Marchal T, Chabanne L, Spadafora A, Magnol JP, Meneguzzi G. Inherited Dystrophic Epidermolysis Bullosa in Inbred Dogs: A Spontaneous Animal Model for Somatic Gene Therapy. J Invest Dermatol. 2000;115: 135–137. pmid:10886525
- 14. Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, et al. TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013;21: 1151–1159. pmid:23546300
- 15. Siprashvili Z, Nguyen NT, Bezchinsky MY, Marinkovich MP, Lane AT, Khavari PA. Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther. 2010;21: 1299–310. pmid:20497034
- 16. Magnol J-, Pin D, Palazzi X, Lacour J-, Gache Y, Meneguzzi G, et al. Characterization of a canine model of dystrophic bullous epidermolysis (DBE). Development of a gene therapy protocol. Bull Acad Natl Med. 2005;189: 107–121. pmid:16119884
- 17. Woodley DT, Keene DR, Atha T, Huang Y, Lipman K, Li W, et al. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med. 2004;10: 693. pmid:15195089
- 18. Woodley DT, Wang X, Amir M, Hwang B, Remington J, Hou Y, et al. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol. 2013;133: 1910–1913. pmid:23321924
- 19. Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJC, Pacy J, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2008;128: 2179–2189. pmid:18385758
- 20. Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12: 429–431. pmid:20230217
- 21. Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363: 629–639. pmid:20818854
- 22. Gache Y, Pin D, Gagnoux-Palacios L, Carozzo C, Meneguzzi G. Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts. J Invest Dermatol. 2011;131: 2069–2078. pmid:21697889
- 23. Niskanen J, Salmela E, Lohi H. AncesTrim—a tool for trimming complex pedigrees. J Open Source Softw. 2017;2.
- 24. Hytönen MK, Arumilli M, Lappalainen AK, Owczarek-Lipska M, Jagannathan V, Hundi S, et al. Molecular Characterization of Three Canine Models of Human Rare Bone Diseases: Caffey, van den Ende-Gupta, and Raine Syndromes. PLoS Genet. 2016;12: e1006037. pmid:27187611